id: lack_effective_therapeutic_agents_to_negative_patient_quality_of_life
name: Lack of Effective Therapeutic Agents for Chronic Pancreatitis â†’ Negative Impact
  on Patient Quality of Life
from_node:
  node_id: lack_effective_therapeutic_agents
  node_name: Lack of Effective Therapeutic Agents for Chronic Pancreatitis
to_node:
  node_id: negative_patient_quality_of_life
  node_name: Negative Impact on Patient Quality of Life
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Absence of effective therapies hampers clinical care capacity to manage
  CP symptoms and complications'
- 'Step 2: Inadequate treatment options lead to persistent pain, nutritional problems,
  and disease-related disability'
- 'Step 3: Ongoing symptoms without effective intervention negatively impact daily
  functioning, work capacity, and psychosocial wellbeing'
- 'Step 4: Structural therapeutic gap creates systematic burden on patients'' lives
  across all domains of health-related quality of life'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'C. Forsmark et al. 2018. "Accelerating the Drug Delivery Pipeline
    for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development
    and Trials in Chronic Pancreatitis at the National Institute of Diabetes and Digestive
    and Kidney Diseases Workshop.." *Pancreas*. https://doi.org/10.1097/MPA.0000000000001174'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.159287'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
